RHEACELL Verwaltungs- und Beteiligungs GmbH

We are a leading clinical late-stage fully integrated biopharmaceutical stem cell company with over 20 years experience based in Heidelberg, Germany.

We focus on innovative stem cell therapies for patients suffering from severe inflammation-driven diseases with high unmet medical need and to provide a new and innovative standard of care for these patients, who currently have no satisfactory treatment options available.

Our ABCB5+ mesenchymal stromal cells as pure drug substance can make a real difference for the lives of these patients, e.g., in Epidermolysis Bullosa, having the potential to be a real game changer.

Targeting inflammation by our innovative proprietary cell therapy enables tissues the recovery of normal physiological function.